Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Rekvina Laboratories Ltd

NSE: VINRKLB · BSE: 526075 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹49.90
Market cap: ₹30.08 Cr
Revenue (annual): ₹1.27 Cr
Net profit (annual): ₹-0.25 Cr
P/E (TTM): -88.5×Sector 50.4×
Promoter holding: 77.00%+35.70% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 3 Financial Results 2 Other Announcement 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

13 Aug 2026 15:48 IST BSE

Financial Results

Rekvina Laboratories Q1 FY27 Results: Net Loss of ₹0.1 Cr

Rekvina Laboratories Ltd reported revenue from operations of ₹0.7 Cr and a net loss of ₹0.1 Cr for Q1 FY27.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗

21 May 2026 20:15 IST BSE

Financial Results

Rekvina Laboratories Q4 FY26 Results: Net Loss of ₹0.1 Cr

Rekvina Laboratories Ltd reported revenue from operations of ₹0.7 Cr and a net loss of ₹0.1 Cr for Q4 FY26.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗